Influence of peripheral arterial disease and supervised walking on heart rate variability  by Leicht, Anthony S. et al.
Influence of peripheral arterial disease and
supervised walking on heart rate variability
Anthony S. Leicht, PhD,a Robert G. Crowther, PhD,a and Jonathan Golledge, MChir,b,c Townsville,
Queensland, Australia
Objective: To examine the influence of peripheral arterial disease (PAD) on heart rate variability (HRV) in patients, and
to examine the influence of an intense long-term (12 months) exercise program on HRV in PAD patients.
Methods: This study involved ambulatory patients attending a local hospital and university center. Participants were
twenty-five patients with diagnosed PAD and intermittent claudication and 24 healthy, age-matched adults. Interven-
tions involved random allocation of PAD patients to 12 months of conservative medical treatment (Conservative) or
medical treatment with supervised treadmill walking (Exercise). The main outcome measures were time- and frequency-
domain, nonlinear HRV measures during supine rest, and maximal walking capacity prior to and following the
intervention.
Results: Despite significantly worse walking capacity (285  190 m vs 941  336 m; P < .05), PAD patients exhibited
similar resting HRV to healthy adults. At the 12-month follow-up, Exercise patients exhibited a significantly greater
improvement in walking capacity (183%  185% vs 57%  135%; P  .03) with similar small nonsignificant changes in
HRV compared with Conservative patients.
Conclusions: The current study demonstrated that PAD patients exhibited similar resting HRV to healthy adults with 12
months of intense supervised walking producing similar HRV changes to that of conservative medical treatment. The
greater walking capacity of healthy adults and PAD patients following supervised exercise does not appear to be associated
with enhanced HRV. (J Vasc Surg 2011;54:1352-9.)
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rPeripheral arterial disease (PAD) is an occlusive disease
of the arteries supplying the lower limbs with a prevalence
of 5.3% for Australian males aged over 65 years.1 The
incidence of new patients with PAD is increasing by 0.85%
annually, presumably due to the increasing age of the
population as well as other known risk factors such as
smoking and physical inactivity.1 The most common symp-
tom of PAD is intermittent claudication (IC), which limits
walking ability and health-related quality of life.2 Treat-
ment options for IC include medications, lifestyle changes,
supervised exercise, and endovascular or surgical interven-
tions.3-5 Supervised exercise has been shown to improve
exercise capacity and quality of life in PAD patients3,6;
however, the mechanisms responsible for these beneficial
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1352ffects are unknown. Suggested means by which supervised
xercise leads to improved walking capacity for PAD pa-
ients include improved angiogenesis and resultant im-
roved tissue perfusion,7 adaptation of the leg muscles to
educed blood flow,8 or central changes such as improved
ardiac performance.9 Identification of the mechanisms by
hich regular exercise improves function and quality of life
ay lead to development of better targeted treatments for
AD patients. One such exercise-induced mechanism may
e an enhanced central cardiac autonomic control. Regular
xercise has been reported to increase cardiac autonomic
ontrol as assessed by heart rate variability (HRV) in older
dults10 and those with known cardiovascular disease.11
he increased HRV and parasympathetic modulation fol-
owing regular exercise have been reported to contribute to
he lower incidence of future arrhythmia and cardiac risk.12
mportantly, regular aerobic exercise has been recognized
s an important nonpharmacological treatment to enhance
RV and cardiac electrical stability13,14 that may lead to a
eduction in cardiac mortality of high-risk populations.15 It
s unclear, however, whether the low intensity of exercise
ossible by patients with intermittent claudication can in-
uce central autonomic changes. A 12-week exercise pro-
ram was reported to increase walking capacity but not
RV in PAD patients.16 The authors suggested the low
ntensity of exercise as a possible factor for the lack of HRV
hange for PAD patients.16 More intense and/or longer
uration exercise programs17 may be necessary for central
ardiac improvements in PAD patients, similar to that
eported for healthy adults.18
Reduced HRV has been reported for patients with
oronary artery disease19 and those at increased risk of
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Volume 54, Number 5 Leicht et al 1353cardiovascular death.20 Most patients with PAD have cor-
onary artery disease,21 and thus it would be assumed they
also have reduced HRV. However, Goernig and col-
leagues22 reported that PAD patients exhibited greater
parasympathetic-based HRV measures compared with pa-
tients with other cardiovascular disease and similar levels to
those of healthy adults.22 These conflicting results high-
light the limited understanding of PAD and HRV that
warrant further examination. The aims of the current study
were: (1) to compare HRV in patients with IC and age-
matched healthy adults; and (2) to examine the influence of
an intense long-term (12-month) exercise program on
HRV in patients with IC.
METHODS
Participants and study design
For aim 1, patients with IC and healthy, aged-matched
adults (n  24) were recruited as previously described
(Fig).4 Patients were assessed by a vascular physician. PAD
was confirmed based on the absence of lower limb periph-
eral pulses, lower limb artery stenosis, or occlusion on
duplex or computed tomographic angiography, and ankle-
brachial pressure index (ABI) 0.9.4 All participants com-
Fig. Line diagram illustrating the number of patients s
study.pleted a general health questionnaire to identify medica- Hions and comorbidities (Table I). Resting HRV, ABI, and
aximal walking capacity during exercise were measured in
ll participants. Following these assessments, IC patients
ere then randomly allocated to either 12 months of
onservative medical treatment (Conservative; n  13) or
ormal medical treatment with regular supervised exercise
Exercise; n 12) in order to assess aim 2 (Fig). Supervised
xercise consisted of treadmill walking of 3 days per week
or 25 to 40 minutes per day at a workload that induced
ntense to maximal claudication pain.4 Assessment of rest-
ng HRV, ABI, and maximal walking capacity were per-
ormed at recruitment (entry) for all participants and 12
onths later for IC patients only. Informed written con-
ent was obtained from all participants with all procedures
ndertaken in accordance with the principles outlined in
he Declaration of Helsinki. Approval for the study was
btained from the local university and health district Re-
earch Ethics Committees.
ssessments
Participants arrived at the laboratory following an
vernight fast and 24-hour absence from physical activ-
ty. Medications were withheld on the testing morning.
ed, recruited, and included within the analyses for thecreeneight was measured using a stadiometer (Seca 202,
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November 20111354 Leicht et alSeca, Hamburg, Germany), and body mass and body fat
percentage were determined using bioelectrical imped-
ance scales (Tanita TBF 521, Tanita Corp. of America,
Arlington Heights, IL). Waist and hip girths were as-
sessed using a steel tape to the nearest millimeter in
accordance with international standards.23 Participants
were then connected to a metabolic analysis system
(Powerlab 8M; ADInstruments Pty Ltd, Bella Vista,
Australia) for the continuous monitoring of heart rate
(HR; Lead II) and respiration during supine rest and
exercise. Participants initially rested supine for 5 minutes
prior to measurement of supine resting HRV and respi-
ration. Then, ABI of both legs were assessed as previ-
ously described.4 Finally, participants undertook a
graded walking test on a motorized treadmill commenc-
ing at 3.2 km/hr and incline of 0%. The incline increased
by 2% every 2 minutes until voluntary exhaustion or a
maximum time of 25 minutes, as previously described.4
Participants were allowed to breathe spontaneously at
their own rate throughout all assessments, as HRV has
been reported to be similar during normal resting
breathing frequencies.24 All HR and respiratory data
were recorded using Chart (ADInstruments) at a sam-
Table I. Characteristics of patients with intermittent
claudication and healthy, aged-matched adults
Intermittent
claudication
(n  25)
Healthy adults
(n  24)
Age (years) 66.9  8.0 65.2  7.7
Height (cm) 166.7  8.5 168.1  7.1
Mass (kg) 80.5  16.3 75.0  12.2
Body fat (%) 32.9  8.2 33.5  7.6
Male 14 (56) 10 (42)
Waist girth (cm) 97.3  14.0 86.9  10.5b
Hip girth (cm) 106.5  10.8 100.9  7.5a
Waist:hip ratio 0.91  0.09 0.86  0.09a
Ankle-brachial index – worst 0.61  0.16 1.14  0.14c
Ankle-brachial index – best 0.85  0.24 1.20  0.15c
Current smoker 7 (28) 0 (0)b
Former smoker 15 (60) 8 (33)b
Diabetes 6 (24) 0 (0)a
Hypertension 10 (40) 6 (25)
Myocardial infarction 8 (32) 0 (0)b
Beta-blocker 6 (24) 1 (4)
Angiotensin-converting
enzyme inhibitor 6 (24) 4 (17)
Statin 10 (40) 3 (13)
Antiplatelet 12 (48) 1 (4)a
Intermittent claudication
distance (m) 114  86
Maximal walking distance
(m) 285  190 941  336c
Peak aerobic capacity (mL ·
kg1 · min1) 18.6  7.2 34.5  7.9c
Values are mean  SD or number (%).
aP  .05 vs intermittent claudication.
bP .01 vs intermittent claudication.
cP .001 vs intermittent claudication.pling rate of 1 kHz and stored for later analysis. data analysis
Respiration. Throughout rest and exercise, expired
ir was analyzed every 15 s for oxygen consumption (VO2),
entilation (VE), respiratory rate (RR), and tidal volume
TV) via indirect calorimetry (Powerlab 8-M Metabolic
ystem).4
HRV. A 5-minute electrocardiogram (ECG) record-
ng during supine rest was reviewed with beats identified as
ither normal or ectopic using an automatic R wave thresh-
ld detector within Chart and then reviewed manually.
ormal-to-normal RR intervals only (94% of recording)
ere utilized for HRV analyses with ectopic beats replaced
sing linear interpolation of the previous and succeeding
ormal intervals. All RR intervals were exported and ana-
yzed using customized software (Kubios HRV v2.0 soft-
are, Biosignal Analysis and Medical Imaging Group,
epartment of Physics, University of Kuopio, Kuopio,
inland).25 The RR interval series was interpolated at 4
z and detrended using a smoothness priors regulariza-
ion procedure26 prior to the calculation of the following
efault time-domain and geometrical parameters: HR;
tandard deviation of all normal-normal RR intervals
SDNN); root mean square of successive differences in
ormal-normal RR intervals (RMSSD); percentage of
uccessive normal-normal RR intervals different by more
han 50 ms (pNN50); and HRV triangular index (area of
R interval histogram divided by the height of the
istogram).27 Frequency-domain components of HRV
low frequency, [LF] 0.04-0.15 Hz; high frequency, [HF]
.15-0.4 Hz) were obtained via power spectral analysis of
he data using an autoregressive model of 20 and expressed
n absolute units (ms2) and normalized units (nu), while
he LF/HF ratio was calculated as a measure of sympa-
hovagal balance.27 Nonlinear HR dynamics were also ex-
mined, as these measures have been reported to be supe-
ior to conventional time- and frequency-domain HRV
easures to document HR behavior.28 The default nonlin-
ar measures examined included the short (SD1, reflecting
hort-term instantaneous RR modulation) and long (SD2,
ong-termRRmodulation) axes of the Poincare plot, Sample-
ntropy (SampEn), and short- (1) and long-term (2)
ractal scaling exponents.25 Fractal scaling components
ere conducted via detrended fluctuation analyses that
alculated the slope of the relationship between the (log)
ntegrated and detrended fluctuation and (log) window
ize. The 1 and 2 values were computed based on
indow sizes of four to 16 beats and 16 to 64 beats,
espectively.25 Heart rate complexity or randomness was
etermined via SampEnwith input variables of m (length of
ompared runs at each time point of the time series)  2
nd r (tolerance for judging the similarity of runs) 20%.25
ampEn has been demonstrated to be independent of record-
ng length and exhibit less bias compared with othermeasures
uch as approximate entropy.29,30 Linear and nonlinear HRV
easures have previously been reported to be reproducible
uring short-term recordings of supine rest.31,32
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Volume 54, Number 5 Leicht et al 1355Walking capacity. Distance to the onset of claudica-
tion pain (ICD), maximal walking distance (MWD), and
peak aerobic capacity (VO2peak) were recorded as previ-
ously described.4
Statistical analysis
Data were expressed as mean standard deviation and
analyzed using the Statistical Package for the Social Sci-
ences (SPSS v17; SPSS Inc, Chicago, Ill). Data normality
was determined using the Kolmogorov-Smirnov statistic
with a Lilliefors significance correction. To assess aim 1,
differences between PAD patients and healthy adults were
examined via independent t tests or MannWhitneyU tests,
where appropriate. To assess aim 2, variables at baseline (0
months) and 12-month changes in variables were com-
pared between groups via independent t tests or Mann
Whitney U tests, where appropriate. Changes in variables
were examined in absolute terms (outcome at 12 months
compared with entry) or as a percentage (outcome at 12
months minus entry/entry value 100) to account for any
potential differences at baseline and the nature of the
variable (ie, some variables were expressed either as a ratio
or a percentage and therefore absolute differences were
more appropriate). Relationships between HRV and ICD,
MWD, and VO2peak were determined via Spearman rank
() correlation coefficients. A P .05 was set as the level of
Table II. HRV and respiratory measures during supine re
aged-matched adults
Time-domain HRV
Heart rate (beats · min1)
Standard deviation of RR (NN) intervals (ms)
Square root of the mean squared differences of successive RR inte
Percentage of successive NN intervals 50 ms (%)
HRV triangular index
Frequency-domain HRV
Low frequency (ms2)
High frequency (ms2)
Low frequency (nu)
High frequency (nu)
Low frequency/high frequency
Nonlinear HRV
SD1 - short axis of Poincare plot (ms)
SD2 - long axis of Poincare plot (ms)
Sample entropy
1 (short-term fractal scaling exponent)
2 (long-term fractal scaling exponent)
Respiratory variables
Tidal volume (L)
Respiratory rate (breaths · min1)
Ventilation (L · min1)
Oxygen consumption (mL · kg1 · min1)
HRV, Heart rate variability; nu, normalized units.
Values are mean  SD.
aP  .05 vs intermittent claudication.significance for all analyses. EESULTS
Comparison between patients with intermittent
laudication and healthy adults. Compared with healthy
dults, PAD patients exhibited a larger waist and hip girth;
larger waist:hip ratio; a greater frequency of current and
ormer smoking; a greater frequency of diabetes mellitus; a
reater history of prior myocardial infarction; a greater use
f antiplatelet medication; and lower ABI, MWD, and
O2peak (Table I). All other descriptive characteristics were
imilar between IC patients and healthy adults (Table I).
During supine rest, PAD patients and healthy adults
xhibited similar time-domain, frequency-domain, and
onlinear measures of HRV (Table II), while PAD patients
reathed at a greater rate compared with healthy adults
Table II).
Effect of supervised exercise on HRV. HRV record-
ngs were not available for all IC patients at the 12-month
ollow-up examination, as eight patients withdrew from the
tudy. The characteristics of patients with complete HRV
nalyses are shown in Table III. The characteristics of these
C patients were similar to the original group of recruited
C patients (P  .31).
At study entry, Conservative and Exercise patients ex-
ibited similar time-domain and nonlinear measures of
RV, while lower LF (ms2), and a trend toward lower LF
nu) and LF/HF, and greater HF (nu), were evident for
patients with intermittent claudication and healthy,
Intermittent claudication
(n  25) Healthy adults (n  24)
68.0  10.1 63.2  8.0
25.6  13.2 30.4  16.1
ms) 27.4  20.5 28.2  21.6
10.5  18.4 8.2  15.5
6.6  2.9 7.8  3.8
336  336 466  365
337  462 448  895
57.0  23.1 62.6  20.0
43.0  23.1 37.4  20.0
2.08  1.80 2.64  2.33
19.6  14.6 20.2  15.3
49.5  20.8 52.4  18.0
1.39  0.36 1.41  0.28
1.10  0.31 1.15  0.29
1.02  0.25 0.91  0.30
0.7  0.5 0.8  0.3
15.2  3.8 13.0  3.1a
8.8  4.8 7.7  1.9
3.5  1.8 3.5  0.8st for
rvals (xercise patients compared with Conservative patients (Ta-
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November 20111356 Leicht et alble IV). At the 12-month follow-up assessment, Exercise
patients had a smaller increase of body fat percentage
compared with the Conservative group (1.2 4.1 vs 2.5
2.3; P .06). The Exercise group had a greater increase in
MWD compared with Conservative (183%  185% vs
57% 135%; P .03) at follow-up. The change in resting
ABI over 12 months was similar for the Exercise and
Conservative patients (ABI-worst: -2.6%  37.5% vs -4.6%
 36.5%; ABI-best: -5.6% 16.7% vs -2.1% 27.6%; P
.76). All time- and frequency-domain HRV measures
changed similarly for Exercise and Conservative patients
(Table V). However, the Exercise group had a greater
increase in SD2 compared with the Conservative group
(Table V). No significant relationships were exhibited be-
tween changes in HRV and changes in ICD, MWD, and
VO2peak between entry and 12 months.
DISCUSSION
The new findings from the current study are two-fold.
First, IC patients exhibited comparable HRV to healthy
age-matched adults during supine rest. Second, 12 months
of supervised treadmill did not influence HRV in IC pa-
tients despite significant improvements in walking capacity.
These findings suggest that changes in autonomic cardiac
control are not responsible for the improved walking capac-
Table III. Characteristics of patients with intermittent
claudication randomized to either 12 months of
conservative medical treatment (Conservative) or medical
treatment with regular supervised walking (Exercise)
Conservative
(n  9)
Exercise
(n  8)
Age (years) 65.0  8.7 68.3  6.1
Height (cm) 164.9  9.5 165.8  9.3
Mass (kg) 73.6  21.0 81.6  13.9
Body fat (%) 30.8  7.8 33.7  8.3
Male 5 (56) 4 (50)
Waist girth (cm) 91.8  16.9 96.2  10.6
Hip girth (cm) 99.9  12.2 109.3  9.2
Waist: hip ratio 0.91  0.10 0.88  0.09
Ankle-brachial index – worst 0.55  0.12 0.62  0.17
Ankle-brachial index – best 0.79  0.28 0.87  0.22
Current smoker 2 (22) 1 (13)
Former smoker 6 (67) 6 (75)
Diabetes 2 (22) 1 (13)
Hypertension 4 (44) 1 (13)
Myocardial infarction 2 (22) 1 (13)
Beta-blocker 4 (44) 1 (13)
Angiotensin-converting
enzyme inhibitor
4 (44) 1 (13)
Statin 2 (22) 3 (38)
Antiplatelet 3 (33) 4 (50)
Intermittent claudication
distance (m) 107  93 116  58
Maximal walking distance (m) 244  172 296  150
Peak aerobic capacity (mL ·
kg1 · min1) 20.0  5.7 19.2  7.6
Values are mean  SD or number (%).ity stimulated by supervised exercise in IC patients. wInfluence of PAD on HRV. The current findings
onfirm that PAD has minimal impact on supine HRV and
ardiac autonomic control. This was an interesting finding
iven that IC patients also exhibited a prior incidence of
ther cardiovascular/metabolic conditions and risk factors
eported to reduce HRV.11,33 The IC patients for the
urrent study were suitable for supervised exercise and thus
ere unlikely to have marked cardiac dysfunction. It is
ossible that significant cardiac dysfunction may be neces-
ary for measurable reductions in HRV and autonomic
ontrol.15 The reported greater HRV for PAD patients
ompared with patients with known cardiac disease22 indi-
ates further that HRV is reduced by significant coronary
rtery disease only. Whether the similar HRV denotes that
C patients have better prognosis in terms of the risk of
ubsequent cardiac events remains to be clarified.
Influence of a 12-month supervised walking pro-
ram on HRV. Regular exercise has been promoted as a
ey component for the treatment of PAD21 with significant
mprovements in walking capacity and quality of life re-
orted following regular exercise for PAD patients.3-6,34
hemechanisms for these improvements are still unknown,
ith improved HRV a possibility. Significant improve-
ents in HRV have been noted following 8 to 26 weeks of
egular exercise in healthy young adults,18 older adults,10
ogs susceptible to cardiac arrhythmias,14 and patients with
ardiovascular disease,11 but not in PAD patients.16 The
urrent, long-term study demonstrated that changes in
ost HRV measures were statistically similar for patients
ndertaking either conservative or exercise treatments de-
pite a significantly greater improvement inMWD for those
ndertaking regular exercise. Although statistically similar,
he HRV changes were chiefly positive for Exercise and
redominantly negative for Conservative patients, suggest-
ng a tendency for improved cardiac autonomic control for
xercise patients. Further, Exercise patients exhibited an
ncreased SD2 compared with Conservative patients, re-
ecting reduced long-term sympathetic modulation35 fol-
owing the supervised exercise program. However, the lack
f significant and consistent HRV improvements with reg-
lar supervised exercise fails to support HRV enhancement
s a contributing mechanism to greater walking capacity.
urther, minimal changes in resting ABI following regular
xercise for the current and other studies36 fail to support
mproved lower limb blood flow as a significant contributor
o improvement in walking capacity. It is likely that other
echanisms are responsible for improved walking capacity.
The intensity of walking that can be undertaken by
atients may limit the ability of exercise to alter HRV in
AD patients.16 Previously, we reported that HRV changes
ere training-intensity dependent for healthy young
dults.18 Subsequently, Exercise patients in the current
tudy undertook exercise at a level of maximal claudication
ain and presumably above their anaerobic threshold.37
alking was completed at an average intensity of 95% to
00% peak HR per session for the entire 12 months, with
his intensity failing to improve HRV. Supervised exercise
as undertaken over a long duration as is recommended for
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Volume 54, Number 5 Leicht et al 1357PAD patients.17 Despite undertaking supervised walking at
a greater intensity and duration than previously re-
ported,16,17 HRV change was similar for both the Exercise
and Conservative groups. These findings imply that it is
unlikely that any treadmill-walking regimen that can be
undertaken by most IC patients will alter HRV.
In the current study, walking resulted in minimal HRV
benefits for IC patients. Whether other modes of exercise,
such as upper limb exercise, may be more effective in
Table IV. HRV measures for patients with intermittent cl
treatment (Conservative) or medical treatment with regula
Time-domain HRV
Heart rate (beats · min1)
Standard deviation of RR (NN) intervals (ms)
Square root of the mean squared differences of successive RR inte
Percentage of successive NN intervals 50 ms (%)
HRV triangular index (ms)
Frequency-domain HRV
Low frequency (ms2)
High frequency (ms2)
Low frequency (nu)
High frequency (nu)
Low frequency/high frequency
Nonlinear HRV
SD1 - short axis of Poincare plot (ms)
SD2 - long axis of Poincare plot (ms)
Sample entropy
1 (short-term fractal scaling exponent)
2 (long-term fractal scaling exponent)
HRV, Heart rate variability; nu, normalized units.
Values are mean  SD.
aP  .05 vs Conservative.
Table V. Change in HRV measures for patients with inter
medical treatment (Conservative) or medical treatment wit
Time-domain HRV
Heart rate (%)
Standard deviation of RR (NN) intervals (%)
Square root of the mean squared differences of successive RR inte
Percentage of successive NN intervals 50 ms (abs)
HRV triangular index (%)
Frequency-domain HRV
Low frequency (ms2, %)
High frequency (ms2, %)
Low frequency (nu, abs)
High frequency (nu, abs)
Low frequency/high frequency (abs)
Nonlinear HRV
SD1 - short axis of Poincare plot (%)
SD2 - long axis of Poincare plot (%)
Sample entropy (abs)
1 (Short-term fractal scaling exponent) (abs)
2 (Long-term fractal scaling exponent) (abs)
abs, Absolute; HRV, heart rate variability; nu, normalized units.
Values are mean  SD.
aP  .05 vs Conservative.stimulating central cardiac changes is unknown. To date, talking has been the most examined and recommended
ode for PAD patients due to its functionality and appli-
ability to enhancement of quality of life.17,21 However,
ther modes may be more beneficial for HRV improve-
ents for PAD patients. For example, 12 to 24 weeks of
pper body ergometry or strength training improved
WD similar to that of treadmill walking,38,39 while 6
eeks of combined walking, cycling, and circuit/resistance
xercise improved MWD and VO to a greater extent
ation prior to 12 months of conservative medical
ervised walking (Exercise)
Conservative (n  9) Exercise (n  8)
65.8  10.1 70.1  10.6
29.5  15.2 21.7  10.4
ms) 30.8  22.4 25.9  19.2
13.0  18.9 9.5  21.1
7.5  3.2 5.9  2.1
470  393 170  196a
430  549 245  242
61.3  17.3 42.4  22.8
38.7  17.3 57.6  22.8
2.35  2.34 1.03  0.86
22.0  16.0 18.5  13.7
55.7  21.3 48.0  25.8
1.44  0.22 1.39  0.41
1.15  0.25 0.92  0.27
1.06  0.08 1.12  0.26
ent claudication during 12 months of conservative
ular supervised walking (Exercise)
Conservative (n  9) Exercise (n  8)
1.2  11.3 8.1  14.8
16.0  23.2 3.0  28.8
%) 9.1  31.5 4.3  31.6
2.2  11.3 2.8  8.7
7.1  27.2 4.3  15.7
32.6  45.2 34.2  103.7
1.7  61.5 2.6  42.8
6.8  15.4 1.8  11.4
6.8  15.4 1.8  11.4
0.70  2.74 0.30  1.05
9.4  31.1 4.5  31.3
20.2  23.2 7.9  31.1a
0.14  0.19 0.01  0.43
0.06  0.34 0.07  0.17
0.05  0.22 0.00  0.29audic
r sup
rvals (mitt
h reg
rvals (2peak
han walking or upper body resistance training alone.40
11
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1
1
1
1
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proved with alternative exercise modes that may be less
painful,39 with the impact of these modes on central cardiac
improvements such as HRV still to be clarified. Further
studies are needed to assess whether other modes of exer-
cise can improve cardiac autonomic control and cardiovas-
cular function in PAD patients. The impact of these exer-
cise regimens on long-term mortality for PAD patients is
required, as the current results indicate that currently rec-
ommended walking regimens do not significantly enhance
HRV that may lower the risk of future cardiac events.
Limitations. The main limitation of the current study
was the small sample size, particularly the number of pa-
tients followed up to 12months. While studies with greater
patient numbers may provide further evidence for the im-
pact of PAD on HRV, comparable results between the
current and prior studies16,22 involving larger patient num-
bers (n 13-27 per group) provide support for the limited
influence of PAD on HRV.
In conclusion, the current study demonstrated that
PAD and healthy aged adults exhibited similar HRV mea-
sures during supine rest, and that 12 months of intense
supervised walking failed to improve HRV measures for IC
patients. It seems unlikely that cardiac autonomic changes
play any important role in the beneficial effect of supervised
exercise on walking capacity in patients with IC.
The authors would like to thank Fiona Young for her
technical assistance with the HRV analyses, and Dr Kun-
warjit Sangla, Associate Professor Frank Quigley, and As-
sociate Professor Warwick Spinks for their assistance with
the study.
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